Literature DB >> 8158685

Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.

R Khokha1.   

Abstract

BACKGROUND: Metalloproteinases participate in the first steps of tumor invasion and subsequent metastasis. Three distinct proteins have been identified as tissue inhibitors of metalloproteinases (TIMPs), and an imbalance between TIMPs and metalloproteinases may be an important factor in tumor progression.
PURPOSE: The purpose of this study was to determine if increased levels of TIMP-1 suppressed the malignant phenotype of B16-F10 melanoma cells in mice.
METHODS: We examined and compared the tumorigenic and metastatic behavior of B16-F10 cells, several independent clonal cell lines that were transfected to overexpress TIMP-1, and a vector-transfected control in both nude (BALB/c) and syngeneic (C56BL/6) mice. Tumor growth was assessed by subcutaneously injecting female nude mice with 10(5) cells of parental or transfected B16-F10 cell lines, and monitoring for the appearance of tumors at the injection site. Tumor size was measured every 2-3 days for 5 weeks. To evaluate the effect of elevated TIMP-1 on metastases, 3 x 10(4) cells were administered by intravenous injection into the tail vein of C57BL/6 mice, and the number of metastases counted on days 14 and 22.
RESULTS: Following subcutaneous injections into nude mice, TIMP-1-overexpressing cells showed a substantial decline in their primary tumor growth, characterized by a reduced tumor incidence (50%-89% versus 100% in controls) and longer periods before the appearance of tumors (15 +/- 1.0 to 19 +/- 3.3 days versus 12 +/- 0.4 days in controls). All TIMP-1 clones showed a reduction in their lung colonization ability (8.2 +/- 1.4 to 48.1 +/- 9.9 versus 59.9 +/- 6.0 metastatic nodules in controls) following intravenous injection into syngenic mice. The number of lung metastases arising from four of the five TIMP-1-overexpressing lines was significantly lower than those formed by parental or control cells.
CONCLUSIONS: The data demonstrate that an overexpression of TIMP-1 directly inhibits the tumorigenic as well as metastatic potential of B16-F10 cells in mice, lending further support to the importance of TIMP-1 in controlling malignancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158685     DOI: 10.1093/jnci/86.4.299

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  47 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction.

Authors:  R Khokha; P Waterhouse
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 4.  Recent advances in the treatment of malignant melanoma with gene therapy.

Authors:  E M Hersh; A T Stopeck
Journal:  Mol Med       Date:  1997-10       Impact factor: 6.354

Review 5.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

6.  Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane.

Authors:  T Shioda; L L Munn; M H Fenner; R K Jain; K J Isselbacher
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation.

Authors:  Tatiana I Ricca; Gangning Liang; Ana Paula M Suenaga; Sang W Han; Peter A Jones; Miriam G Jasiulionis
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 9.  Steps in tumor metastasis: new concepts from intravital videomicroscopy.

Authors:  A F Chambers; I C MacDonald; E E Schmidt; S Koop; V L Morris; R Khokha; A C Groom
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 10.  Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors.

Authors:  R Khokha; D C Martin; J E Fata
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.